Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J D Van Der Endt

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Cutis|February 1, 1996
A comparison of the safety, tolerability, and efficacy of fluticasone propionate ointment, 0.005%, and betamethasone-17,21-dipropionate ointment, 0.05%, in the treatment of eczemaJ Delescluse, J D van der Endt
Acta Urologica Belgica|January 1, 1993
[Genital herpes]M H Libert, J D Van Der Endt, J Delescluse
Journal of the European Academy of Dermatology and Venereology : JEADV|July 11, 2001
Melanoma screening: results of the first one-day campaign in Belgium ('melanoma Monday')M M Vandaele, B Richert, J D Van der Endt, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Cutis|February 1, 1996
A comparison of the safety, tolerability, and efficacy of fluticasone propionate ointment, 0.005%, and betamethasone-17,21-dipropionate ointment, 0.05%, in the treatment of eczemaJ Delescluse, J D van der Endt
Acta Urologica Belgica|January 1, 1993
[Genital herpes]M H Libert, J D Van Der Endt, J Delescluse
Journal of the European Academy of Dermatology and Venereology : JEADV|July 11, 2001
Melanoma screening: results of the first one-day campaign in Belgium ('melanoma Monday')M M Vandaele, B Richert, J D Van der Endt, et al.
Pageof 1